Structural and compositional determinants of cortistatin activity

Cortistatin‐14 (CST‐14) is a putative novel neuropeptide that shares 11 of its 14 residues with somatostatin‐14 (SRIF‐14), yet its effects on sleep physiology, locomotor behavior and hippocampal function are different from those of somatostatin. We studied the structural basis for cortistatin's distinct biological activities. As with SRIF‐14, CST‐14 does not show any preferred conformation in solution, as determined by circular dichroism and nuclear magnetic resonance. Synthetic cortistatin analogs were designed and synthesized based on the cyclic structure of octreotide. Biological assays were carried out to determine their binding affinities to five somatostatin receptors (sst1‐5) and their ability to produce changes in locomotor activity and to modulate hippocampal physiology and sleep. The results show that the compound with N‐terminal proline and C‐terminal lysine amide exhibits cortistatin‐like biological activities, including reduction of population spike amplitudes in the hippocampal CA1 region, decrease in locomotor activity and enhancement of slow‐wave sleep 2. These findings suggest that both proline and lysine are necessary for cortistatin binding to its specific receptor. J. Neurosci. Res. 56:611–619, 1999.  © 1999 Wiley‐Liss, Inc.

[1]  H. Loosli,et al.  SMS 201-995, a very potent analogue of somatostatin. Assignment of the 1H 500 MHz n.m.r. spectra and conformational analysis in aqueous solution. , 2009, International journal of peptide and protein research.

[2]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[3]  D. Hoyer,et al.  [125I]Tyr10-cortistatin14 labels all five somatostatin receptors , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  D. Hoyer,et al.  [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors. , 1998, European journal of pharmacology.

[5]  M. Connor,et al.  Cortistatin increase of a potassium conductance in rat locus coeruleus in vitro , 1997, British journal of pharmacology.

[6]  J. Krueger,et al.  Changes in rat sleep after single and repeated injections of the long-acting somatostatin analog octreotide. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  S. Henriksen,et al.  Cortistatin Is Expressed in a Distinct Subset of Cortical Interneurons , 1997, The Journal of Neuroscience.

[8]  G. Liapakis,et al.  Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies. , 1997, Journal of medicinal chemistry.

[9]  J. Sutcliffe,et al.  Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin. , 1997, Genomics.

[10]  S. Hinuma,et al.  Identification and characterization of a novel human cortistatin-like peptide. , 1997, Biochemical and biophysical research communications.

[11]  G. Melacini,et al.  Multiconformational NMR analysis of sandostatin (octreotide): equilibrium between beta-sheet and partially helical structures. , 1997, Biochemistry.

[12]  A. Ullrich,et al.  A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Koob,et al.  Appetite-Suppressing Effects of Urocortin, a CRF-Related Neuropeptide , 1996, Science.

[14]  P. Emson,et al.  Somatostatin receptors in the central nervous system , 1996, Progress in Neurobiology.

[15]  G. Liapakis,et al.  Identification of Ligand Binding Determinants in the Somatostatin Receptor Subtypes 1 and 2* , 1996, The Journal of Biological Chemistry.

[16]  O. Prospero-Garcia,et al.  A cortical neuropeptide with neuronal depressant and sleep-modulating properties , 1996, Nature.

[17]  D. Hoyer,et al.  Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain , 1995, Neuropharmacology.

[18]  J. Strnad,et al.  Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2. , 1995, Biochemical and biophysical research communications.

[19]  W. Meyerhof,et al.  Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding. , 1995, DNA and cell biology.

[20]  S. Tejero,et al.  Opiate microinjections in the locus coeruleus area of the cat enhance slow wave sleep , 1995, Neuropeptides.

[21]  T. Reisine,et al.  Molecular properties of somatostatin receptors , 1995, Neuroscience.

[22]  J. Epelbaum,et al.  Molecular pharmacology of somatostatin receptors , 1995, Fundamental & clinical pharmacology.

[23]  R. Lydic,et al.  Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist. , 1995, British journal of anaesthesia.

[24]  F. Raulf,et al.  Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201‐995 for the SSTR2 somatostatin receptor. , 1995, The EMBO journal.

[25]  O. Prospero-Garcia,et al.  Pharmacology of ethanol and glutamate antagonists on rodent sleep: A comparative study , 1994, Pharmacology Biochemistry and Behavior.

[26]  I. Lucki,et al.  Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[27]  S. Henriksen,et al.  Effects of baclofen and bicuculline on inhibition in the fascia dentata and hippocampus regio superior , 1991, Brain Research.

[28]  R. Quirion,et al.  Evidence that Somatostatin Enhances Endogenous Acetylcholine Release in the Rat Hippocampus , 1990, Journal of neurochemistry.

[29]  H. Imura,et al.  Barrel rotation in rats induced by SMS 201–995: Suppression by ceruletide , 1990, Pharmacology Biochemistry and Behavior.

[30]  Stanley J. Watson,et al.  The rat brain in stereotaxic coordinates (2nd edn) by George Paxinos and Charles Watson, Academic Press, 1986. £40.00/$80.00 (264 pages) ISBN 012 547 6213 , 1987, Trends in Neurosciences.

[31]  F. Bloom,et al.  Somatostatin selectively enhances acetylcholine-induced excitations in rat hippocampus and cortex. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Danguir.  Intracerebroventricular infusion of somatostatin selectively increases paradoxical sleep in rats , 1986, Brain Research.

[33]  N. Swerdlow,et al.  Behavioral changes following central injection of cysteamine in rats , 1986, Brain Research.

[34]  M. Beal,et al.  Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. , 1985, Science.

[35]  B. Penke,et al.  Comparative studies with somatostatin and cysteamine in different behavioral tests on rats , 1984, Pharmacology Biochemistry and Behavior.

[36]  P. Marbach,et al.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. , 1982, Life sciences.

[37]  A. Tashjian,et al.  Modulation of somatostatin receptors by thyrotropin-releasing hormone in a clonal pituitary cell strain. , 1980, The Journal of biological chemistry.

[38]  H. Friesen,et al.  Cortical administration of somatostatin (SRIF): Effect on sleep and motor behavior , 1976, Pharmacology Biochemistry and Behavior.

[39]  D. Hoyer,et al.  The elusive nature of cerebellar somatostatin receptors: studies in rat, monkey and human cerebellum. , 1997, Journal of receptor and signal transduction research.

[40]  B. Ozenberger,et al.  A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14. , 1995, Molecular pharmacology.

[41]  A. Heine,et al.  Structure of octreotide, a somatostatin analogue. , 1995, Acta crystallographica. Section D, Biological crystallography.

[42]  J. Reubi,et al.  Somatostatin Receptors , 1997, Trends in Endocrinology & Metabolism.

[43]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .